{{Rsnum
|rsid=13347
|Gene=CD44
|Chromosome=11
|position=35231725
|Orientation=plus
|GMAF=0.3457
|Gene_s=CD44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 66.1 | 29.5 | 4.5
| HCB | 50.0 | 40.4 | 9.6
| JPT | 55.8 | 37.2 | 7.1
| YRI | 4.8 | 37.4 | 57.8
| ASW | 19.3 | 54.4 | 26.3
| CHB | 50.0 | 40.4 | 9.6
| CHD | 41.3 | 54.1 | 4.6
| GIH | 64.4 | 33.7 | 2.0
| LWK | 15.5 | 49.1 | 35.5
| MEX | 48.3 | 43.1 | 8.6
| MKK | 22.4 | 53.2 | 24.4
| TSI | 60.8 | 32.4 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22788972
|Title=CD44 rs13347 C&gt;T polymorphism predicts breast cancer risk and prognosis in Chinese populations
|OA=1
}}

{{PMID Auto
|PMID=23883608
|Title=Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population
}}

{{PMID Auto
|PMID=23940692
|Title=CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population
|OA=1
}}

{{PMID Auto
|PMID=22213266
|Title=Functional polymorphism rs7072793 C > T affect individual susceptibility to breast cancer by modulating CD25 transcription activity.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}